Adipose Tissue Insulin Resistance in Gestational Diabetes

Area of Science:

• Endocrinology and Metabolism
• Molecular Biology
• Reproductive Medicine

Background:

• Gestational diabetes mellitus (GDM) is a condition marked by insulin resistance and disrupted glucose-lipid metabolism during pregnancy.
• Ectonucleotide pyrophosphate phosphodiesterase-1 (ENPP1) is implicated in adipocyte insulin resistance.
• This study investigates ENPP1's role as a potential determinant of GDM.

Purpose of the Study:

• To examine ENPP1 expression in the adipose tissue (AT) of obese pregnant women with and without GDM.
• To assess glucose tolerance in pregnant mice with AT-specific overexpression of ENPP1.

Main Methods:

• Collected AT biopsies and plasma from obese pregnant women (GDM and non-GDM) and nonpregnant controls.
• Measured key insulin signaling and glucose-lipid metabolism molecules in AT.
• Assessed plasma glucose and insulin, calculated HOMA-IR, and performed intraperitoneal glucose tolerance tests in transgenic mice.

Main Results:

• Obese GDM patients exhibited significantly higher AT ENPP1 expression compared to obese non-GDM patients and controls.
• ENPP1 expression correlated negatively with glucose transporter 4 (GLUT4) and positively with insulin receptor substrate-1 (IRS-1) serine phosphorylation.
• Elevated AT ENPP1 levels were positively correlated with HOMA-IR, and pregnant ENPP1 transgenic mice showed impaired glucose tolerance.

Conclusions:

• Findings suggest a causative link between ENPP1 and metabolic dysregulation in GDM.
• ENPP1 may mediate insulin resistance and hyperglycemia in GDM by affecting insulin signaling, glucose uptake, and lipid metabolism in adipose tissue.